Enveric Biosciences (ENVB) Capital Expenditures (2016 - 2023)
Enveric Biosciences' Capital Expenditures was -$15.00 in Q4 2023, compared with $6,193 a year earlier.
Powered by 
Analysis
Enveric Biosciences (ENVB) Capital Expenditures (2016 - 2023) Analysis & Trends
For FY2023, Capital Expenditures at Enveric Biosciences came in at $5,180, down 99.1% from FY2022.
- In earlier years, Capital Expenditures was $584,165 in FY2022 (+207.9%), $189,719 in FY2021 and $84,331 in FY2019.
- The Q4 2023 figure marks the lowest quarterly Capital Expenditures since Q2 2020.
- Per Business Quant data, ENVB's Capital Expenditures in the three quarters before Q4 2023 was $8.00 (Q3 2023), $18.00 (Q2 2023) and $5,169 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -15.00 |
| Sep 30, 2023 | 8.00 |
| Jun 30, 2023 | 18.00 |
| Mar 31, 2023 | 5,169.00 |
| Dec 31, 2022 | 6,193.00 |
| Sep 30, 2022 | 18,574.00 |
| Jun 30, 2022 | 53,891.00 |
| Mar 31, 2022 | 505,507.00 |
| Sep 30, 2020 | 6,167.00 |
| Jun 30, 2020 | -3,405.00 |
| Mar 31, 2020 | 43,374.00 |
| Dec 31, 2019 | 56,633.00 |
| Jun 30, 2019 | 15,775.00 |
| Mar 31, 2019 | 11,923.00 |
| Dec 31, 2018 | -17,981.00 |
| Sep 30, 2018 | -2,315.00 |
| Jun 30, 2018 | 13,875.00 |
| Dec 31, 2017 | -2,957.00 |
| Sep 30, 2017 | -3.00 |
| Jun 30, 2017 | -2,693.00 |
API Access
Enveric Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();